NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Barrick Gold

(ABX)

downgraded at BMO from Outperform to Market Perform, BMO Capital said. $46 price target. Estimates also cut, as the company is facing higher operating costs.

Berry Petroleum

(BRY) - Get Report

downgraded at Wunderlich from Buy to Hold, Wunderlich said. $40 price target. Company is seeing slower production growth.

CBOE

(CBOE) - Get Report

upgraded at KBW from Underperform to Market Perform, Keefe, Bruyette & Woods said. $30 price target. Volatility complex is growing and the company may soon pay a special dividend.

Charter Communications

(CHTR) - Get Report

rated new Hold at Deutsche. $83 price target. Company faces numerous operational challenges.

Eldorado Gold

(EGO) - Get Report

rated new Overweight at Morgan Stanley. $19 price target. Company can deliver industry-leading growth over the next several years.

Exelon

(EXC) - Get Report

downgraded at Jefferies from Buy to Hold, Jefferies said. $34 price target. Company is seeing lower prices and may have to cut its dividend.

Fluor

(FLR) - Get Report

downgraded at Baird from Outperform to Neutral, Robert Baird said. $62 price target. Backlog is likely to trend lower.

First Solar

(FSLR) - Get Report

downgraded at Cantor from Buy to Hold, Cantor Fitzgerald said. Valuation call, based on a $23 price target.

Guess

(GES) - Get Report

downgraded at Jefferies Buy to Hold, Jefferies said. $25 price target. Company continues to lose managers and lacks near-term catalysts.

Iconix

(ICON) - Get Report

upgraded at Benchmark from Hold to Buy, Benchmark said. $23 price target. Company is carrying a lot of momentum into the new year and buying back stock.

Lifepoint Hospitals

(LPNT)

downgraded at Cantor from Buy to Hold, Cantor Fitzgerald said. $35 price target. Company has relatively weak earnings leverage.

Las Vegas Sands

(LVS) - Get Report

downgraded at Cantor from Buy to Hold, Cantor Fitzgerald said. $46 price target. Company is seeing slower growth in Singapore.

Mednax

(MD) - Get Report

upgraded at Deutsche from Sell to Hold, Deutsche Bank said. $76 price target. Company is posting higher volumes and margins.

Pioneer Natural

(PXD) - Get Report

downgraded at Canaccord from Hold, Canaccord Genuity said. Valuation call, based on a $110 price target.

Rockwell Automation

(ROK) - Get Report

upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $91 price target. Expect a catch up of pent-up demand to cause growth to re-accelerate in the coming quarters.

True Blue

(TBI) - Get Report

upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $16 price target. Company is leveraged to rising ISM new orders index and could see more demand following Hurricane Sandy.

Vertex Pharmaceuticals

(VRTX) - Get Report

downgraded at Goldman from Neutral to Sell, Goldman Sachs said. $43 price target. Have a more cautious outlook for the company's cystic fibrosis portfolio.

Watson Pharmaceuticals

(WPI)

upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $103 price target. Company offers growth at a reasonable price.

STOCK COMMENTS / EPS CHANGES

LinkedIn

(LNKD)

numbers boosted at Citi. Shares of LNKD now seen reaching $135, according to Citigroup. Estimates also upped, as the company is gaining market share. Buy rating.

Priceline.com

(PCLN)

numbers raised at Goldman. Shares of PCLN now seen reaching $770, according to Goldman Sachs. Estimates also increased, as the company is realizing higher bookings growth. Buy rating.

Pfizer

(PFE) - Get Report

estimates, target reduced at BMO. PFE estimates were cut through 2013, BMO Capital said. Company is being hurt by the stronger dollar. Outperform rating and new $29 price target.

Starbucks

(SBUX) - Get Report

estimates, target raised at BofA/Merrill. Shares of SBUX now seen reaching $60, according to Bank of America/Merrill Lynch. Estimates also increased, as new products are driving growth. Buy rating.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>Like It or Not, Apple Will Be Apple

>>What the Hell Is Happening at Apple?

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.